Method for isolating extracellular vesicles from biological material not belonging to the animal kingdom
Patent Information
- Application Number
- EP2023705060
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-01-18
- Filing Date
- 2023-01-17
- Publication Date
- 2024-11-27
AI Technical Summary
Current methods for isolating extracellular vesicles (EVs) from biological materials outside the animal kingdom, such as plants, are non-standardizable and result in low yield and purity due to mechanical pretreatment methods that introduce contaminants and degrade biomolecules, limiting their integrity and effectiveness for diagnostic and pharmacological applications.
A method involving enzymatic digestion between pretreatment and isolation steps, using specific digestive enzymes to break down plant cell walls and release EVs, improving their yield and purity, and allowing for the isolation of EVs with dimensions ranging from 40 nm to 220 nm, enhancing their integrity and applicability.
The method achieves a high yield and purity of EVs, up to 90% free from protein residues and contaminants, maintaining their biological integrity, and enabling their use in various formulations for effective pharmacological and physiological applications.
Smart Images

Figure 1.1
Abstract
Description
[0001] "METHOD FOR ISOLATING EXTRACELLULAR VESICLES FROM BIOLOGICAL MATERIAL NOT BELONGING TO THE ANIMAL KINGDOM"
[0002] Cross-Reference to Related Applications
[0003] This patent application is related to Italian Patent Application No . 102022000000719 filed on January 18 , 2022 , the entire disclosure of which is incorporated herein by reference .
[0004] Technical Field
[0005] The present invention concerns a method for isolating extracellular vesicles (EVs ) from biological material not belonging to the animal kingdom . In particular, the present invention concerns a method for isolating extracellular vesicles of nanometric and sub-micrometric dimensions from biological material not belonging to the animal kingdom .
[0006] Extracellular vesicles (EVs ) comprise a wide variety of membrane-limited particles released from the cells of any organism . Speci fically, EVs are small particles consisting of a double lipid layer that holds within it di f ferent categories of biomolecules such as proteins , lipids , nucleic acids , enzymes and sugars . EVs are heterogeneous in content , surface composition and dimensions ; therefore , all vesicles with a diameter ranging from 40 nm to 5 pm actively released by cells fall under the definition of EVs .
[0007] Background
[0008] It has been observed that the biomolecules contained in EVs vary greatly depending on the dimensions of the EVs , the type of source cell from which they are released and the state of the source cell (physiological , trans formed, di f ferentiated, stimulated, stressed, etc . ) .
[0009] Since their discovery in the 1980s in the context of studies on reticulocytes , EVs were for a long time mistakenly regarded as simple biocomponents adopted by cells to eliminate unwanted proteins and other unnecessary molecules .
[0010] Recently, however, their key role in short- and longdistance intercel lular communication has emerged . By virtue of their ability to transport biomolecules and to contain receptors for ligands exposed on the membrane of target cells , EVs can influence the behaviour of target cells through multiple communication mechanisms .
[0011] Several studies have shown that communication can take place by direct contact , through the binding of the receptor on the surface of the EVs with the respective ligand on the target cell or by fusion of the EVs with the plastic membrane of the target cell . Alternatively, communication may occur by release of the biomolecules of the EVs into the cytosol of the target cell .
[0012] More recently it has been shown that EVs contain and can therefore carry not only proteins or lipids , but also messenger RNA (mRNA) , microRNA (miRNA) , pre-miRNA and other non-coding RNAs , which are then translated into the target cell with consequent activation or inhibition of certain cellular processes in the target cell depending on the genetic information trans ferred .
[0013] EVs therefore represent natural transporter systems for biomolecules , the trans fer of which into the target cell can lead to important changes in the activity, migration, proli feration and survival of the cell itsel f .
[0014] In addition, EVs represent a way of communicating between cells of the same organism, between cells of di f ferent organisms , but also an extra-species and extrakingdom communication mechanism . In fact , bacteria and fungi are able to produce EVs capable of communicating with the host , and the plant cells release EVs capable of trans ferring biomolecules not only between cell s of the same species but also to cells of di f ferent kingdoms . Thanks to the key role as mediators in intercellular communication processes and all the unique features illustrated above , EVs are of great interest both in basic research and in future diagnostic, physiological and pharmacological applications . With reference to the pharmacological field, many studies are in fact focused on evaluating their therapeutic use in relation to the ef fects of the biomolecules naturally contained in EVs . In addition, EVs are recently considered promising alternatives to liposomes in relation to the possibility of introducing drugs into the EVs that can subsequently be conveyed into the body, exploiting the ability of the EVs to speci fically recogni ze the target cell .
[0015] Despite the great attention paid to EVs in biological and biomedical research, the known techniques for their isolation from biological material are not very standardisable and do not guarantee the integrity of the isolated EVs as a fundamental requirement for downstream applications .
[0016] The techniques reported so far for the isolation of EVs largely concern the category of smaller EVs with nanometer dimensions starting from biological material belonging to the animal kingdom .
[0017] However, to date , the techniques developed for isolating EVs from biological material not belonging to the animal kingdom are limited in number and have severe limitations .
[0018] It is known that the techniques for isolating EVs from, for example , plant tissues involve a step of pretreatment of the sample following which the EVs are isolated . Generally, the step of pretreatment of the plant tissue is of a mechanical type : in fact , the fragmentation of the plant tissue is obtained by using blades and filters . The EVs are isolated from the fragmented matter .
[0019] However, the step of pretreatment of mechanical type presents critical issues that inevitably reflect on the quality and quantity of the EVs isolated from the pretreated biological material .
[0020] The main critical issues are attributable to the high level of contaminants ( including protein aggregates ) that co-sediment together with the EVs , af fecting the yield and the purity of the final product , and to the degradation of biomolecules due to the time and conditions of pretreatment , altering the integrity of the isolated EVs and compromising subsequent applications in the diagnostic, physiological and pharmacological fields .
[0021] A method for extracting extracellular vesicles from plants , speci fically from the root of the Morinda of ficinalis plant , is described in the article "An enzyme-based system for the extraction of small extracellular vesicles from plant" by Q . Zhao at al . This method envisages enzymatically degrading the cell wall of the plant , with consequent release of EVs of diameter ranging from 50 to 80 nm contained therein .
[0022] However, even this method is not without limitation, for example the di fficulty of obtaining a correct digestive step with less impurities .
[0023] The method described in the aforementioned article will be used as a comparative example with respect to the method of the present invention .
[0024] It is therefore felt necessary and important to develop a method for isolating EVs from biological material not belonging to the animal kingdom that does not present the disadvantages found in the known techniques .
[0025] Summary
[0026] It is therefore an aim of the present invention the development of a method for isolating EVs of nanometric and sub-micrometric dimensions starting from biological material not belonging to the animal kingdom that allows to obtain a signi ficantly higher yield of isolated EVs , without altering the biological properties of the source and editable material at low cost .
[0027] In accordance with this aim, the present invention is therefore related, in general terms , to a method for isolating EVs of nanometric and sub-micrometric dimensions starting from biological material not belonging to the animal kingdom, in particular from biological material of plant origin, as defined in basic terms in appended Claim 1 .
[0028] Further preferred features of the invention are defined in the dependent Claims .
[0029] The method of the invention is therefore advantageous in that it provides a step of enzymatic digestion inserted between an initial step of pretreatment of the biological starting material and a final step of isolation of the EVs from the treated sample . In this step of enzymatic digestion, the pretreated sample is subj ected to the action of speci fic digestive enzymes , which allow to supply at the final step of isolation of the EVs a product with improved characteristics compared to the product obtained from the step of pretreatment alone or from the step of digestion alone in the absence , therefore , of the step of pretreatment .
[0030] The use of digestive enzymes makes it possible to degrade the cells included in the pretreated biological material and favour the release of EVs still trapped in them . In particular, in the case where the starting biological material is represented by plant tissues , enzymatic digestion is responsible for the degradation of wall and matrix components of plant cells with consequent release of the EVs contained therein . It should be noted that the step of pretreatment of the biological material , in particular of plant biological material , facil itates the subsequent step of enzymatic digestion and allows to ef fectively eliminate cells and cellular debris , thus helping to increase the purity of the isolated EVs .
[0031] Surprisingly, the use of digestive enzymes in the step of enzymatic digestion has proved particularly ef fective in facilitating and maximi zing the final step of isolation of the EVs .
[0032] The method of the invention also allows to isolate EVs of nanometric and sub-nanometric dimensions , in particular the EVs isolated according to the method of the invention have dimensions ranging from 40 nm to 220 nm . Said EVs isolated according to the present method have di f ferent biological functions compared to EVs of smaller diameter, for example ranging from 50 to 80 nm, isolated instead with known methods .
[0033] Therefore , the method of the invention has numerous advantages over known techniques for isolating EVs and lacking the step of enzymatic digestion or lacking the step of pretreatment prior to the step of enzymatic digestion, including a high degree of purity of the isolated EVs equal to about 90% due to the absence of protein residues , waste and extracellular material ; a high yield; a high integrity of the final product and a high plasticity in pharmacological and physiological applications . In relation to the latter advantageous aspect, the EVs isolated by the method of the invention can be incorporated in any formulations e . g . creams , lotions , mouthwashes , in aerosol , in polymeric and non-polymeric materials . Said EVs , included in any formulation, may be administered to a human or living animal by any suitable route of administration, for example orally, nasally, enterally, topically, sublingually, intraarterially, ocularly, transdermally, vaginally, rectally, alone or in combination with a carrier .
[0034] Brief Description of the Drawings
[0035] The features and advantages of the present invention will become apparent from the description detailed below, from the examples provided for illustrative and non-limiting purposes , and from the accompanying Figures 1-5 , wherein :
[0036] Figure 1 shows the graph of the si ze distribution and concentration of the isolated EVs according to an embodiment of the method of the present invention and described in Example 1 ;
[0037] Figure 2 shows a series of Transmission Electron Microscope ( TEM) photographs of the isolated EVs according to the same embodiment of the method of the present invention and described in Example 1 ;
[0038] Figure 3 shows the internali zation of the EVs isolated again according to the embodiment of the present method and described in Example 1 inside human mesenchymal stem cells ;
[0039] Figure 4 shows a visual comparison of the isolated EVs according to a further embodiment of the method of the invention and described in Example 3 and the isolated EVs according to a comparative method described in Example 4 ; and
[0040] Figure 5 shows the comparison of protein concentration in the isolated EVs according to the same embodiment described in Example 3 and in the isolated EVs according to the same comparative method described in Example 4 .
[0041] Description of Embodiments
[0042] The present invention describes an innovative method for isolating EVs from biological material not belonging to the animal kingdom comprising a step of pretreatment (A) , a step (B ) of enzymatic digestion and a step ( C ) of isolation .
[0043] For the purposes of the present invention, the term "not belonging to the animal kingdom" means all organisms , both unicellular and multicellular, of the plant kingdom, the fungal kingdom and the bacterial kingdom .
[0044] The term "biological material" means any biological material derived from organisms not belonging to the animal kingdom .
[0045] The biological material may be fresh or may have been stored ( e . g . frozen or refrigerated) .
[0046] According to a particularly preferred aspect of the present invention, the biological material belongs to the plant kingdom, for example it comes directly from the plants or the fruits generated by them . In the case of fruits , the biological material can come either from the seeds ( endosperm, embryo and integument ) and / or from the pericarp ( endocarp, mesocarp and exocarp ) .
[0047] According to a further preferred aspect , the biological material is represented by plant tissues , for example by the mesocarp and / or exocarp of a fruit , preferably of an apple .
[0048] The method of the present invention initially comprises the step (A) of pretreatment of the biological material not belonging to the animal kingdom .
[0049] In accordance with one embodiment of the invention, said step of pretreatment (A) comprises :
[0050] - a step (Al ) of disaggregating the biological material by mechanically cutting it into fragments ranging from 10 to 100 pm in si ze , obtaining a disaggregated biological material , and at least one centri fugation of the disaggregated biological material for removing cells and cellular debris larger than 50 pm in si ze , wherein a supernate , resulting from said at least one centri fugation, is collected, obtaining the pretreated biological material ;
[0051] For example , a relative centri fugal force of 650 g is applied to said at least one centrifugation for 15 minutes at 4°C.
[0052] For example, the step (A) of pretreatment comprises two centrifugations following the step (Al) of disaggregating the biological material.
[0053] Thus, for example, the step (A) of pretreatment comprises the following steps subsequent to step (Al) of disaggregating the biological material:
[0054] (A2) centrifuging the disaggregated biological material of step (Al ) ,
[0055] (A3) collecting a supernate resulting from the step (A2) of centrifugation,
[0056] (A4) resuspending the supernate obtained at step (A3) in a physiological solution or Murashige and Skoog culture medium for protoplasts, obtaining a resuspended supernate,
[0057] (A5) centrifuging the resuspended supernate of step (A4) ,
[0058] (A6) collecting a supernate obtained at step (A5) , obtaining the pretreated biological material.
[0059] For example, relative centrifugal forces of 650 g are applied to the steps (A2) and (A5) of centrifugation for 15 minutes at 4°C.
[0060] Preferably, the step (A5) of centrifugation is repeated in series at least three times.
[0061] The saline solution is preferably an aqueous solution containing NaCl in concentration ranging from 0.5 to 3%. For example, the saline solution is a phosphate buffer (PBS) containing bovine serum albumin (BSA) , for example at the concentration of about 0.5%.
[0062] Alternatively, step (A4) of resuspending the supernate obtained during step (A3) takes place in the Murashige and Skoog culture medium for protoplasts which allows to increase cell viability during the next step (B) of digestion, reducing stress, and increasing the yield of the produced vesicles .
[0063] Preferably, this culture medium comprises a compound selected from the group consisting of potassium phosphate monobasic (170 mg / 1) , potassium nitrate (1900 ng / 1) , magnesium sulphate (180 mg / 1) , ammonium nitrate (1650 mg / 1) , cobalt chloride (0.025 mg / 1) , copper sulphate (0.025 mg / 1) , boric acid (6.2 mg / 1) , ETDA disodium salt (37.3 mg / 1) , potassium iodide (0.83 mg / 1) , magnesium sulphate (16.9 mg / 1) , iron sulphate (27.8 mg / 1) , sodium molybdate (0.25 mg / 1 ) , zinc sulphate (8.6 mg / 1 ) , calcium chloride (440 mg / 1 ) , glycine (2 mg / 1) , myo-inositol (100 mg / LTR) , pyridoxine (0.5 mg / 1) , thiamine (0.1 mg / 1) , nicotinic acid (0.5 mg / 1) and mixtures thereof.
[0064] The pretreated biological material, without cells and cellular debris, to be subjected to the next step (B) of enzymatic digestion is obtained, as described above, from the step (A) of pretreatment.
[0065] In particular, during the step (B) of enzymatic digestion, the pretreated biological material is subjected to enzymatic digestion, obtaining an EVs suspension.
[0066] Preferably, the step of enzymatic digestion is carried out for a time ranging from 1 and 15 hours, more preferably between 15 and 180 minutes, at a temperature ranging from 30 and 38°C, more preferably between 35 and 38°C, at pH ranging from 4 and 7 in agitation of the pretreated biological material .
[0067] The step of enzymatic digestion can be carried with enzymes selected from exogenous fibrolytic enzymes, e.g. amylase, laccase, cellulase haemylcellulase, pectinase, xylanase, glucanase, arabinase and expansin-like proteins of battery or fungal origin, hydrolytic enzymes, e.g. exogenous pectolytic enzymes, polygalacturonase, pectin methylesterase and pectate lyase, and combinations thereof.
[0068] Said enzymes are able to degrade wall components and cell matrix of cells still included in the pretreated biological material, and favour the release of the EVs still trapped in them.
[0069] By "expansin-like protein" it is meant non-hydrolytic bacterial enzymes (produced inter alia by Bacillus subtilis) similar in function and adaptability of substrate to expansins, plant proteins involved in the breakdown of glycosidic bonds necessary to modify the cell wall. The use of such enzymes facilitates the hydrolysis of cellulose by hydrolytic enzymes, increasing accessibility to the substrate within the cellulose matrix. They are used to increase the digestibility of biomass for the production of biogas and animal feed.
[0070] In accordance with one embodiment of the invention, step of (B) of enzymatic digestion is carried out by one or more exogenous fibrolytic enzymes selected from the group consisting of amylase, laccase, cellulase, haemylcellulase, pectinase, xylanase, glucanase, arabinase and expansin-like proteins of battery or fungal origin.
[0071] Advantageously, in fact, the use of such exogenous fibrolytic enzymes allows to break down the cell wall, consisting of complex sugars and organized into three main structures, such as cellulose, hemicellulose and pectins, with consequent release of EVs.
[0072] Said step (B) of enzymatic digestion improves, in fact, the release of EVs from the masocarp and / or exocarp, rich in cellulose and pectins.
[0073] In accordance with a further embodiment of the invention, step (B) of enzymatic digestion further provides a further step (Bl) of depectini zation using one or more exogenous pectolytic enzymes. Step (B) and step (Bl) may be carried out consecutively or simultaneously. For example, step (Bl) precedes step (B) .
[0074] Advantageously, the step (Bl) of depectinization allows to control the viscosity of the EV extraction medium. In fact, thanks to the use of exogenous pectolytic enzymes, pectin, responsible for increasing the viscosity of the EV extraction medium, is degraded.
[0075] Preferably, the step (Bl) of depectinization in turn comprises one or more sub-steps, for example (Bl.l) , (Bl.2) and (Bl.3) , which can be carried out consecutively or simultaneously with the use of one or more hydrolase enzymes.
[0076] For example, the step (Bl) of depectinization comprises the following sub-steps:
[0077] (Bl.l) hydrolyzing by polygalacturonase at least one main chain of homogalacturonans , releasing subunits of oligosaccharides and galacturonic acid;
[0078] (Bl.2) hydrolyzing by pectin methylesterase at least one subunit of galacturonic acid, releasing the acid functions of galacturonic acid from methanol; and
[0079] (Bl.3) hydrolyzing by lyase pectate at least one chain of homogalacturonans by oxidation.
[0080] Advantageously, the sub-steps, for example (Bl.l) , (Bl.2) and (Bl.3) , of step (Bl) , of depectinization allow the degradation of the side chains released from depectinization, in addition to the degradation into oligosaccharides and monosaccharides of hemicellulose and cellulose, thanks to the use of hydrolytic enzymes, for example polygalacturonase, pectin methylesterase and pectate lyases .
[0081] The step (B) of enzymatic digestion is followed by the step (C) of isolation of the EVs starting from the EVs suspension, resulting from the enzymatic digestion.
[0082] In accordance with an embodiment of the invention, said step (C) of isolation comprises:
[0083] - at least one centrifugation of the EVs suspension obtained at step (B) of enzymatic digestion, to block enzymatic digestion,
[0084] - at least one filtration of a supernate collected from said at least one centrifugation, obtaining a filtrate,
[0085] - at least one centrifugation of the filtrate, obtaining a precipitate.
[0086] For example, relative centrifugal forces of 1000 g are applied to said at least one centrifugation of the EVs suspension and to said at least one centrifugation of the filtrate for 10 minutes at 5°C.
[0087] Preferably, said at least one filtration is carried out with a filter having pore diameter ranging from 0.10 pm to 0.22 pm, so that the filtrate comprises EVs of dimensions (in diameter) less than 0.22 pm.
[0088] For example, the step (C) of isolation comprises two centrifugations starting from the EVs suspension obtained at step (B) of digestion and said at least one filtration can be carried out through several passages using initially filters with pore diameter ranging from 0.30 pm to 0.45 pm. Thus, for example, the step (C) of isolation comprises the following steps of:
[0089] (Cl) centrifuging the EVs suspension obtained at step (B) ,
[0090] (C2) collecting a supernate resulting from the step (Cl) of centrifugation,
[0091] (C3) resuspending the supernate collected at step (C2) in a saline solution, obtaining a resuspended supernate,
[0092] (C4) centrifuging the resuspended supernate obtained at step (C3 ) ,
[0093] (C5) collecting a supernate resulting from the step (C4) of centrifugation, (C6) filtering the supernate collected at step (C5) with a filter having a pore diameter ranging from 0.30 pm to 0.45 pm, obtaining a first filtrate,
[0094] (C7) resuspending the first filtrate in a saline solution, obtaining a resuspended first filtrate,
[0095] (C8) centrifuging the first resuspended filtrate,
[0096] (C9) collecting a supernate resulting from the step (C8) of centrifugation,
[0097] (CIO) filtering the supernate collected at step (C9) with a filter having pore diameter ranging from 0.10 pm to 0.22 pm, obtaining a second filtrate,
[0098] (Cll) centrifuging the second filtrate,
[0099] (C12) removing a supernatant resulting from the step (Cll) of centrifugation, obtaining a precipitate.
[0100] For example, the steps (C4) , (C8) and (Cll) of centrifugation are each repeated in series at least three times .
[0101] For example, a relative centrifugal force of 60000 g is applied to the step (C8) of centrifugation of the first resuspended filtrate for 10 minutes at 5°C.
[0102] The first filtrate comprises EVs of dimensions (in diameter) less than 0.45 pm, while the second filtrate comprises EVs of dimensions (in diameter) less than 0.22 pm.
[0103] Therefore, the precipitate obtained at step (C12) comprises isolated EVs of nanometric or sub-micrometric dimensions, preferably EVs of dimensions less than 0.22 pm, more preferably EVs of dimensions ranging from 40 nm to 220 nm.
[0104] The isolated EVs according to the method of the invention can be used fresh or stored at 4°C, in lyophilized form, or cryofrozen using appropriate cryogenic or vitrifying reagents.
[0105] Examples The following are experimental examples describing the isolation of EVs from biological material, such as apple pulp, according to two embodiments of the method in accordance with the invention and the experimental characterization of said isolated EVs.
[0106] 1. Isolation of EV from the apple pulp according to an embodiment of the method of the present invention .
[0107] The biological material from which EVs are isolated is apple pulp.
[0108] Isolation of EVs from the apple pulp is carried out as follows :
[0109] (Al) disaggregating the apple pulp by mechanically cutting it into fragments of 100 pm,
[0110] (A2) centrifuging at 650 g for 15 minutes at 4°C to remove fragments of dimensions larger than 40 pm,
[0111] (A3) collecting the supernate,
[0112] (A4) resuspending the supernate in physiological solution represented by aqueous solution containing 0.9% NaCl and
[0113] (A5) repeating the centrifugation three times,
[0114] (B) adding to the supernate resulting from the third centrifugation enzymes such as amylase, cellulase, pectinase, xylanase, glucanase and arabinase laccases, hemilcellulase and expansin-like proteins of battery or fungal origin, in agitation for 180 minutes at 37°C and pH 5, and collecting the suspension,
[0115] (Cl) centrifuging the suspension at 1000 g for 10 minutes at 5°C,
[0116] (C2) collecting the supernate,
[0117] (C3) resuspending the supernate in physiological solution (aqueous solution containing NaCl in concentration ranging from 0.5 to 3%) ,
[0118] (C4) repeating the centrifugation three times, (C5) collecting the supernate resulting from each centrifugation,
[0119] (C6) filtering the supernate resulting from the third centrifugation with 0.45 pm filter,
[0120] (C7-9) collecting the filtrate, resuspending it in physiological solution and centrifuging it at 60000 g for 10 minutes at 5°C for three times,
[0121] (CIO) filtering the supernate resulting from the third centrifugation with 0.22 pm filter, obtaining a filtrate comprising EVs of dimensions less than 0.22 pm and collecting the filtrate,
[0122] (Cll) centrifuging thereof at 1000 g for 10 minutes at 5°C three times,
[0123] (C12) removing the supernate resulting from the third centrifugation and collecting the precipitate in which the isolated EVs are included.
[0124] 2. Characterization of the EVs isolated from the apple pulp.
[0125] The EVs isolated according to the procedure of Example 1 were subjected to the Bradford technique for the quantification of the proteins contained therein. A protein concentration of about 8-25 pg / pl was then determined.
[0126] The isolated EVs according to Example 1 were analysed to determine their dimensions and concentration using the Tunable Resistive Pulse Sensing (TRPS) technique. Figure 1 shows the size and concentration distribution obtained with the TRPS technique with reference to two groups of EVs isolated from two different apple pulp samples. The dimensions of the EVs were found to be in a diameter interval ranging from 40 to 160 nm for both groups of EVs.
[0127] Other experimental tests found dimensions of the EVs ranging from 40 nm to 220 nm.
[0128] The morphological characterization of the isolated EVs according to Example 1 was performed with transmission electron microscope (TEM) . The related images shown in Figure 2 confirmed that the isolated EVs are from 40 to 160 nm in size and maintain their spherical structure.
[0129] The biological activity of the isolated EVs as described in Example 1 was validated by labelling them with a green fluorescent probe (PKH67, Sigma) . The PKH67-labelled EVs were then incubated for 3 hours in complete DMEM culture medium plus 20% fetal bovine serum with human stem mesenchymal cells that recognized them by internalizing them. As shown in Figure 3, the mesenchymal cells incorporate green-labelled EVs into the cellular cytoplasm.
[0130] 3. Isolation of EV from the apple pulp according to a second embodiment of the method of the present invention .
[0131] Like for Example 1, the biological material from which EVs are isolated is apple pulp and, specifically, Golden delicious pulp.
[0132] The isolation of EVs from the apple pulp follows the steps indicated in Example 1 as a whole with some differences, such as:
[0133] - the step (A4) of resuspending the supernate obtained at step (A3) takes place in the Murashige and Skoog culture medium for protoplasts containing monobasic potassium phosphate (170 mg / 1) ,
[0134] - the step (B) of enzymatic digestion takes place in agitation for 180 minutes at the temperature of 37°C and pH 5 and comprises, in succession, the step (Bl) of depectinization with pectinase enzymes, the step (Bl.2) of hydrolyzing by polygalacturonase at least one main chain of homogalacturonans , releasing subunits of oligosaccharides and galacturonic acid, the step (Bl.2) of hydrolyzing by pectin methylesterase at least one subunit of galacturonic acid, releasing the acid functions of galacturonic acid from methanol, the step (Bl.3) of hydrolyzing by pectate lyases at least one chain of homogalacturonans by oxidation; and the step (B) with the enzymes amylase, laccase, cellulase, haemylcellulase, pectinase, xylanase, glucanase, arabinase and expansin-like enzymes of battery or fungal origin
[0135] The remaining steps relating to the isolation step (C) , from (Cl) to (C12) , correspond to those of Example 1.
[0136] 4. Isolation of EV from the apple pulp according to a comparative method.
[0137] Like for Example 1 and 3, the biological material from which EVs are isolated is apple pulp and, specifically, Golden delicious pulp.
[0138] The isolation of EVs from the apple pulp follows a comparative method, described in the prior art mentioned above ("An enzyme-based system for the extraction of small extracellular vesicles from plants" by Q. Zhao et al.) and here summarised:
[0139] (1) cutting of the apple pulp into fractions equal to 1 mm in size;
[0140] (2) 1:1:1 volume enzymatic digestion, i.e. cut apple pulp:MES Buffer (0.1% MES, 1 mmol / L CaC12, pH5.5) :cellulase RIO, pectinase RIO, haemicellulase, and incubate for 2 hours at room temperature;
[0141] (3) consecutive centrifuges of the supernate, such as:
[0142] - at 500 g for 10 minutes and discarding the pellet,
[0143] - at 2000 g for 20 minutes and discarding the pellet,
[0144] - at 5000 g for 30 minutes and discarding the pellet,
[0145] - at 10000 g for 60 minutes and discarding the pellet,
[0146] - at 100000 g for 70 minutes and collect the pellet;
[0147] (4) resuspending the pellet in 1 mL PBS and filter it with 0.22 pm filter.
[0148] Compared to the method in accordance with the invention of Examples 1 and 3, the comparative method comprises a step (1) similar to step (Al) of the present method, although the fragments obtained in Examples 1 and 3 have quantities lower (by 100 pm) than those obtained in the comparative method. Furthermore, the comparative method does not comprise the steps from (A2) to (A5) of pretreatment.
[0149] The step (2) of digestion of the comparative method does not comprise the step (Bl) and sub-steps (Bl.l) , (Bl.2) , (Bl.3) of the enzymatic digestion of Example 3. Furthermore, unlike the step (B) of enzymatic digestion of Examples 1 and 3 according to the invention, the step (2) of digestion of the comparative method does not involve the use of the enzymes amylase, lacase, xylanase, glucanase, arabinase and expansin-like proteins of battery or fungal origin.
[0150] Steps (3) and (4) of the comparative method are similar to steps (C) and its sub-steps (C1)- (C12) of Example 1 and 3 with some differences.
[0151] 5. Visual evaluation and quantification of the protein concentration of the isolated EVs in accordance with the second embodiment of this method and in accordance with the comparative method.
[0152] The isolated EVs according to the procedure of Example 3 and according to the comparative method of Example 4 were subjected to a visual evaluation.
[0153] The relative images reported in Figure 4 confirmed that the EVs isolated in Example 3, in accordance with the method of the invention, result in a neutral coloured extract (Figure 4A) having well-defined edges, indicating that no cellular residues of different density are present and that all pigments present in the extract have been removed.
[0154] In contrast, the isolated EVs in Example 4, according to the comparative method, result in a brown-coloured extract (Figure 4B) , index of high pigment contamination, and a pronounced halo that demonstrates the poor purity of the vesicles extracted with this methodology .
[0155] The isolated EVs in Example 3 and 4 were also subj ected to the Bradford technique for quanti fication of the total protein portion in extracted fractions , as shown in Figure 5 .
[0156] Although the visual analysis of the extract ( Figure 4 ) indicates a higher deposition of biological material with the comparative method than the present method, the protein concentration ( Figure 5 ) indicates a signi ficantly higher protein concentration in the fraction of EVs isolated with the method according to the invention (ADNV_INV) compared to EVs isolated with the comparative method (ADNV_comp ) .
[0157] From the above description and from the above examples , the advantages achieved by the method according to the present invention are evident .
Claims
CLAIMS1. Method for isolating extracellular vesicles (EVs) of nanometric and sub-micrometric dimensions from biological material not belonging to the animal kingdom comprising sequentially : a step (A) of pretreatment comprising: a step (Al) of disaggregating the biological material by mechanically cutting it into fragments ranging from 10 to 100 pm in size, obtaining a disaggregated biological material, and at least one centrifugation of the disaggregated biological material for removing cells and cellular debris larger than 50 pm in size, wherein a supernate, resulting from said at least one centrifugation, is collected, obtaining a pretreated biological material; a step (B) of enzymatic digestion, wherein the pretreated biological material is subjected to enzymatic digestion, obtaining an extracellular vesicles (EVs) suspension; and a step (C) of isolation of the extracellular vesicles (EVs) from said extracellular vesicles (EVs) suspension.
2. Method for isolating extracellular vesicles (EVs) according to Claim 1, wherein the biological material is a plant tissue.
3. Method for isolating extracellular vesicles (EVs) according to Claim 2, wherein the plant tissue is a mesocarp and / or an exocarp of a fruit, particularly of an apple.
4. Method for isolating extracellular vesicles (EVs) according to Claim 1, wherein a relative centrifugal force of 650 g is applied to said at least one centrifugation for 15 minutes at 4°C.
5. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step(Al) of disaggregating the biological material is followed by two centrifugations, comprising the steps of:(A2) centrifuging the disaggregated biological material of step (Al) ,(A3) collecting a supernate resulting from the step (A2) of centrifugation,(A4) resuspending the supernate obtained at step (A3) in a physiological solution or Murashige and Skoog culture medium for protoplasts, obtaining a resuspended supernate,(A5) centrifuging the resuspended supernate of step (A4) ,(A6) collecting a supernate resulting from step (A5) , obtaining the pretreated biological material.
6. Method for isolating extracellular vesicles (EVs) according to Claim 5, wherein the Murashige and Skoog culture medium for protoplasts comprises a compound selected from the group consisting of potassium phosphate monobasic (170 mg / 1) , potassium nitrate (1900 ng / 1) , magnesium sulphate (180 mg / 1) , ammonium nitrate (1650 mg / 1) , cobalt chloride (0.025 mg / 1) , copper sulphate (0.025 mg / 1) , boric acid (6.2 mg / 1) , ETDA disodium salt (37.3 mg / 1) , potassium iodide (0.83 mg / 1) , magnesium sulphate (16.9 mg / 1) , iron sulphate (27.8 mg / 1) , sodium molybdate (0.25 mg / 1) , zinc sulphate (8.6 mg / 1) , calcium chloride (440 mg / 1) , glycine (2 mg / 1) , myoinositol (100 mg / 1) , pyridoxine (0.5 mg / 1) , thiamine (0.1 mg / 1) , nicotinic acid (0.5 mg / 1) and mixtures thereof.
7. Method for isolating extracellular vesicles (EVs) according to Claim 5 or 6, wherein the step (A5) of centrifugation is repeated in series at least three times.
8. Method for isolating extracellular vesicles (EVs) according to one of Claims 5 to 7, wherein the physiologicalsolution is represented by an aqueous solution containing a NaCl concentration ranging from 0.5 to 3%.
9. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step (B) of enzymatic digestion is carried out with enzymes selected from exogenous fibrolytic enzymes, e.g. amylase, laccase, cellulase haemylcellulase, pectinase, xylanase, glucanase, arabinase and expansin-like proteins of battery or fungal origin, hydrolytic enzymes, e.g. exogenous pectolytic enzymes, polygalacturonase, pectin methylesterase and pectate lyase, and combinations thereof.
10. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step (B) of enzymatic digestion is carried out with one or more exogenous fibrolytic enzymes selected from the group consisting of amylase, laccase, cellulase, haemylcellulase, pectinase, xylanase, glucanase, arabinase and expansin-like proteins of battery or fungal origin.
11. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step (B) of enzymatic digestion comprises a further step (Bl) depectinization using one or more exogenous pectolytic enzymes .
12. Method for isolating extracellular vesicles (EVs) according to Claim 11, wherein the step (Bl) of depectinization comprises the following sub-steps:(Bl.l) hydrolyzing by polygalacturonase at least one main chain of homogalacturonans , releasing subunits of oligosaccharides and galacturonic acid;(Bl.2) hydrolyzing by pectin methylesterase at least one subunit of galacturonic acid, releasing the acid functions of galacturonic acid from methanol; and(Bl.3) hydrolyzing by lyase pectate at least one chain of homogalacturonans by oxidation.
13. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step(B) of enzymatic digestion is carried out for a time ranging from 1 to 15 hours, preferably between 15 and 180 minutes, at the temperature ranging from 30°C to 38°C, preferably between 35°C and 38°C at pH ranging from 4 to 7 in agitation of the pretreated biological material.
14. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the step(C) of isolation comprises: at least one centrifugation of the extracellular vesicles (EVs) suspension obtained at step (B) of enzymatic digestion, at least one filtration of a supernate collected from said at least one centrifugation, obtaining a filtrate, at least one centrifugation of the filtrate, obtaining a precipitate.
15. Method for isolating extracellular vesicles (EVs) according to Claim 14, wherein a relative centrifugal force of 1000 g is applied to said at least one centrifugation of the extracellular vesicles (EVs) suspension and to said at least one centrifugation of the filtrate for 10 minutes at 5°C.
16. Method for isolating extracellular vesicles (EVs) according to Claim 14 or 15, wherein said at least one filtration is carried out with a filter having pore diameter ranging from 0.10 pm to 0.22 pm.
17. Method for isolating extracellular vesicles (EVs) according to one of the Claims from 14 to 16, wherein thestep (C) of isolation comprises the steps of(Cl) centrifuging the suspension of extracellular vesicles (EVs) obtained at step (B) of enzymatic digestion,(C2) collecting a supernate resulting from the step (Cl) of centrifugation,(C3) resuspending the supernate collected at step (C2) in a saline solution, obtaining a resuspended supernate,(C4) centrifuging the resuspended supernate obtained at step (C3 ) ,(C5) collecting a supernate resulting from the step (C4) of centrifugation,(C6) filtering the supernate collected at step (C5) with a filter having a pore diameter ranging from 0.30 pm to 0.45 pm, obtaining a first filtrate, (C7) resuspending the first filtrate in a physiological solution, obtaining a resuspended first filtrate, (C8) centrifuging the first resuspended filtrate, (C9) collecting a supernate resulting from the step (C8) of centrifugation,(CIO) filtering the supernate collected at step (C9) with a filter having a pore diameter ranging from 0.10 pm to 0.22 pm, obtaining a second filtrate, (Cll) centrifuging the second filtrate,(C12) removing a supernate resulting from the step (Cll) of centrifugation, obtaining the precipitate.
18. Method for isolating extracellular vesicles (EVs) according to Claim 17, wherein the steps (C4) , (C8) and (Cll) of centrifugation are each repeated in series at least three times .
19. Method for isolating extracellular vesicles (EVs) according to Claim 17 or 18, wherein a relative centrifugal force of 60000 g is applied to the step (C8) of centrifugation for 10 minutes at 5°C.
20. Method for isolating extracellular vesicles (EVs) according to one of the previous Claims, wherein the extracellular vesicles (EVs) isolated in the step (C) range in size (in diameter) from 40 nm to 220 nm.
